Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
  1. 4 Open-market buy Director bought 12,000 shares at an average $0.84 ($10,066)
  2. 4 Open-market buy Director bought 18,300 shares at $0.83 ($15,189)
  3. 4 Open-market buy Chairman, Pres. & CEO bought 25,000 shares at $0.82 ($20,500)
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 8-K Event Other events
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 8-K Event Executive or director change · Shareholder vote results
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 8-K Event Other events
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 1 of 45 · 897 filings